GGrantIndex
← Leaderboards

Vinayaka R Prasad

Yeshiva University

$32,898,539
Attributed
$34,719,573
Total exposure
13
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$38,304,994 · 14

By mechanism

R01$12,333,270 · 5
T32$6,637,129 · 1
P30$6,492,115 · 3
R37$4,391,626 · 1
D43$3,819,841 · 1
P01$3,585,421 · 1

Top collaborators

Others in their field

Top investigators on “Base

Research focus

BaseAids/Hiv ProblemVirusCollaborationsHiv-1ProteinsAcquired Immunodeficiency SyndromeCellsResearch PersonnelSeriesPathogenesisIn VitroIndiaTrainingGenesAffectProgramsGrantMacrophageMutationMutantLeadApplications GrantsViral

Grant awards (102)

ERC Einstein Rockefeller CUNY Center for AIDS Research$375,000
P30 · FY2025 · AI · contact PI
CCL2-CCR2b signaling in HIV-1 fitness and disease; Role of host genetic polymorphisms$533,727
R01 · FY2024 · AI · contact PI
ERC Einstein Rockefeller CUNY Center for AIDS Research$356,297
P30 · FY2024 · AI · contact PI
Training in HIV/AIDS Pathogenesis; Basic and Translational Research$350,287
T32 · FY2024 · AI · contact PI
ERC Einstein Rockefeller CUNY Center for AIDS Research$971,403
P30 · FY2023 · AI · contact PI
CCL2-CCR2b signaling in HIV-1 fitness and disease; Role of host genetic polymorphisms$533,727
R01 · FY2023 · AI · contact PI
Training in HIV/AIDS Pathogenesis; Basic and Translational Research$349,472
T32 · FY2023 · AI · contact PI
ERC Einstein Rockefeller CUNY Center for AIDS Research$1,751,080
P30 · FY2022 · AI · contact PI
CCL2-CCR2b signaling in HIV-1 fitness and disease; Role of host genetic polymorphisms$594,452
R01 · FY2022 · AI · contact PI
Training in HIV/AIDS Pathogenesis; Basic and Translational Research$284,526
T32 · FY2022 · AI · contact PI
CCL2-CCR2b signaling in HIV-1 fitness and disease; Role of host genetic polymorphisms$655,178
R01 · FY2021 · AI · contact PI
Developmental Core$361,433
P30 · FY2021 · AI · contact PI
Training in HIV/AIDS Pathogenesis; Basic and Translational Research$328,191
T32 · FY2021 · AI · contact PI
Effect of Drugs of Abuse on CNS HIV-1 Reservoirs and Neuropathogenesis$9,504
R01 · FY2021 · DA · contact PI
CCL2-CCR2b signaling in HIV-1 fitness and disease; Role of host genetic polymorphisms$699,203
R01 · FY2020 · AI · contact PI
Effect of drugs of abuse on CNS HIV-1 reservoirs and neuropathogenesis$625,731
R01 · FY2020 · DA · contact PI
Developmental Core$452,355
P30 · FY2020 · AI · contact PI
Training in HIV/AIDS Pathogenesis; Basic and Translational Research$307,173
T32 · FY2020 · AI · contact PI
Developmental Core$1,132,807
P30 · FY2019 · AI · contact PI
Effect of drugs of abuse on CNS HIV-1 reservoirs and neuropathogenesis$625,731
R01 · FY2019 · DA · contact PI
Training in HIV/AIDS Pathogenesis; Basic and Translational Research$289,805
T32 · FY2019 · AI · contact PI
Effect of drugs of abuse on CNS HIV-1 reservoirs and neuropathogenesis$5,767
R01 · FY2019 · DA · contact PI
Effect of drugs of abuse on CNS HIV-1 reservoirs and neuropathogenesis$372,736
R01 · FY2018 · DA · contact PI
Effect of drugs of abuse on CNS HIV-1 reservoirs and neuropathogenesis$252,995
R01 · FY2018 · DA · contact PI
Training in HIV/AIDS Pathogenesis; Basic and Translational Research$185,861
T32 · FY2018 · AI · contact PI
Developmental Core$160,380
P30 · FY2018 · AI · contact PI
Training in HIV/AIDS Pathogenesis; Basic and Translational Research$87,577
T32 · FY2018 · AI · contact PI
Developmental Core$71,796
P30 · FY2018 · AI · contact PI
Effect of drugs of abuse on CNS HIV-1 reservoirs and neuropathogenesis$13,093
R01 · FY2018 · DA · contact PI
Effect of drugs of abuse on CNS HIV-1 reservoirs and neuropathogenesis$625,731
R01 · FY2017 · DA · contact PI
Training in HIV/AIDS Pathogenesis; Basic and Translational Research$248,132
T32 · FY2017 · AI · contact PI
Developmental Core$158,203
P30 · FY2017 · AI · contact PI
Training in HIV/AIDS Pathogenesis; Basic and Translational Research$2,592
T32 · FY2017 · AI · contact PI
Effect of drugs of abuse on CNS HIV-1 reservoirs and neuropathogenesis$642,481
R01 · FY2016 · DA · contact PI
The role of viral and cellular proteins in early events of HIV-1 replication$456,358
R37 · FY2016 · AI · contact PI
Training in HIV/AIDS Pathogenesis; Basic and Translational Research$221,314
T32 · FY2016 · AI · contact PI
The role of viral and cellular proteins in early events of HIV-1 replication$266,210
R37 · FY2015 · AI · contact PI
Training in HIV/AIDS Pathogenesis; Basic and Translational Research$255,136
T32 · FY2015 · AI · contact PI
The role of viral and cellular proteins in early events of HIV-1 replication$190,148
R37 · FY2015 · AI · contact PI
Training in HIV/AIDS Pathogenesis; Basic and Translational Research$12,261
T32 · FY2015 · AI · contact PI
The role of viral and cellular proteins in early events of HIV-1 replication$456,358
R37 · FY2014 · AI · contact PI
HIV, AIDS and Opportunistic Infections$246,075
T32 · FY2014 · AI · contact PI
Targeting CNS HIV reservoirs across the blood-brain barrier$214,146
R21 · FY2014 · MH · contact PI
The role of viral and cellular proteins in early events of HIV-1 replication$428,976
R37 · FY2013 · AI · contact PI
HIV, AIDS and Opportunistic Infections$260,868
T32 · FY2013 · AI · contact PI
Targeting CNS HIV reservoirs across the blood-brain barrier$254,154
R21 · FY2013 · MH · contact PI
Developmental Core$67,939
P30 · FY2013 · AI · contact PI
Dissecting the Role of HIV-1 Tat & Chemokine Axis in Subtype-Specificity of HAD$573,854
R01 · FY2012 · MH · contact PI
The role of viral and cellular proteins in early events of HIV-1 replication$455,219
R37 · FY2012 · AI · contact PI
HIV, AIDS and Opportunistic Infections$265,188
T32 · FY2012 · AI · contact PI
Developmental Core$154,330
P30 · FY2012 · AI · contact PI
Dissecting the Role of HIV-1 Tat and the Chemokine Axis in Subtype-Specificity of$576,736
R01 · FY2011 · MH · contact PI
The role of viral and cellular proteins in early events of HIV-1 replication$449,088
R37 · FY2011 · AI · contact PI
International Training in AIDS/TB Prevention Research$300,000
D43 · FY2011 · TW · contact PI
HIV, AIDS and Opportunistic Infections$248,330
T32 · FY2011 · AI · contact PI
Developmental Core$140,110
P30 · FY2011 · AI · contact PI
Dissecting the Role of HIV-1 Tat and the Chemokine Axis in Subtype-Specificity of$587,768
R01 · FY2010 · MH · contact PI
The role of viral and cellular proteins in early events of HIV-1 replication$440,411
R37 · FY2010 · AI · contact PI
International Training in AIDS/TB Prevention Research$398,220
D43 · FY2010 · TW · contact PI
HIV, AIDS and Opportunistic Infections$208,287
T32 · FY2010 · AI · contact PI
Developmental Core$102,212
P30 · FY2010 · AI · contact PI
Dissecting the Role of HIV-1 Tat and the Chemokine Axis in Subtype-Specificity of$579,033
R01 · FY2009 · MH · contact PI
The role of viral and cellular proteins in early events of HIV-1 replication$419,892
R37 · FY2009 · AI · contact PI
International Training in AIDS/TB Prevention Research$398,220
D43 · FY2009 · TW · contact PI
HIV AIDS and Opportunistic Infections$303,083
T32 · FY2009 · AI · contact PI
Developmental Core$115,301
P30 · FY2009 · AI · contact PI
Dissecting the Role of HIV-1 Tat and the Chemokine Axis in Subtype-Specificity of$602,829
R01 · FY2008 · MH · contact PI
The role of viral and cellular proteins in early events of HIV-1 replication$413,720
R37 · FY2008 · AI · contact PI
International Training in AIDS/TB Prevention Research$398,166
D43 · FY2008 · TW · contact PI
HIV AIDS and Opportunistic Infections$301,214
T32 · FY2008 · AI · contact PI
Developmental Core$121,469
P30 · FY2008 · AI · contact PI
Blocking HIV with aptamers targeted to viral components$913,516
P01 · FY2007 · AI · contact PI
The role of viral and cellular proteins in early events of HIV-1 replication$415,246
R37 · FY2007 · AI · contact PI
International Research Training in the Prevention of HIV/AIDS and Opportunistic I$398,220
D43 · FY2007 · TW · contact PI
HIV AIDS and Opportunistic Infections$171,403
T32 · FY2007 · AI · contact PI
International Training in AIDS/TB Prevention Research$100,000
D43 · FY2007 · TW · contact PI
Blocking HIV with aptamers targeted to viral components$918,623
P01 · FY2006 · AI · contact PI
International Training in AIDS/TB Prevention Research$423,638
D43 · FY2006 · TW · contact PI
Delineating Viral Determinants of HAD using SCID Mice$275,891
R21 · FY2006 · MH · contact PI
HIV AIDS and Opportunistic Infections$239,020
T32 · FY2006 · AI · contact PI
Blocking HIV with aptamers targeted to viral components$917,110
P01 · FY2005 · AI
Drug Resistant HIV Reverse Transcriptase$511,493
R01 · FY2005 · AI
Delineating Viral Determinants of HAD using SCID Mice$301,401
R21 · FY2005 · MH
HIV AIDS and Opportunistic Infections$300,614
T32 · FY2005 · AI
INTERNATIONAL TRAINING IN AIDS/TB PREVENTION RESEARCH$155,159
D43 · FY2005 · TW
Blocking HIV with aptamers targeted to viral components$836,172
P01 · FY2004 · AI
Drug Resistant HIV Reverse Transcriptase$496,596
R01 · FY2004 · AI
INTERNATIONAL TRAINING IN AIDS/TB PREVENTION RESEARCH$254,704
D43 · FY2004 · TW
HIV, AIDS AND OPPORTUNISTIC INFECTIONS$252,409
T32 · FY2004 · AI
Drug Resistant HIV Reverse Transcriptase$482,132
R01 · FY2003 · AI
INTERNATIONAL TRAINING IN AIDS/TB PREVENTION RESEARCH$254,553
D43 · FY2003 · TW
HIV, AIDS AND OPPORTUNISTIC INFECTIONS$244,409
T32 · FY2003 · AI
Drug Resistant HIV Reverse Transcriptase$468,323
R01 · FY2002 · AI
HIV, AIDS AND OPPORTUNISTIC INFECTIONS$242,584
T32 · FY2002 · AI
INTERNATIONAL TRAINING IN AIDS/TB PREVENTION RESEARCH$229,553
D43 · FY2002 · TW
Drug Resistant HIV Reverse Transcriptase$477,858
R01 · FY2001 · AI
NOVEL RTS FOR CONSTRUCTION OF FULL-LENGTH CDNA LIBRARIES$398,890
R01 · FY2001 · CA
INTERNATIONAL TRAINING IN AIDS/TB PREVENTION RESEARCH$254,704
D43 · FY2001 · TW
HIV, AIDS AND OPPORTUNISTIC INFECTIONS$222,992
T32 · FY2001 · AI
NOVEL RTS FOR CONSTRUCTION OF FULL-LENGTH CDNA LIBRARIES$387,702
R01 · FY2000 · CA
INTERNATIONAL TRAINING IN AIDS/TB PREVENTION RESEARCH$254,704
D43 · FY2000 · TW
HIV, AIDS AND OPPORTUNISTIC INFECTIONS$208,326
T32 · FY2000 · AI